Phase 3 ADHD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children (boys or girls) aged 7 to 14 years old who are able to participate and cooperate with the study requirements
- A parent or legal guardian must agree to take part and sign a consent form, and the child may also need to sign an agreement form depending on their age and understanding
- The child must have been diagnosed with ADHD (combined type) based on specific assessment tools used by a doctor
- The child must have a high enough ADHD symptom score (at least 32) on a standard rating scale at the first visit
- The child must have a minimum severity rating of 4 on a clinical scale at the first visit (confirm with trial site)
- The child must have an age-appropriate level of intelligence, measured by a standard IQ test (full IQ score above 80)
- Children who previously tried stimulant medication but stopped due to side effects may be eligible, as long as they have not taken the medication for at least 7 days before joining
Who may not be able to join:
- Children who have a neurological condition such as epilepsy, cerebral palsy, or lasting effects from a brain injury
- Children who have certain other mental health conditions, such as autism, severe OCD, mood disorders, bipolar disorder, psychosis, conduct disorder, or substance misuse
- Children who are currently taking stimulant medications, other psychiatric medications, antidepressants, sleeping tablets, melatonin, or benzodiazepines — or children whose ADHD did not improve with stimulant medication in the past
- Children who have a serious sleep disorder
- Children for whom the study treatment (a type of mild brain stimulation called tDCS) is not considered safe (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (33)3 22 08 76 70
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Variation of ADHD-RS(ADHD Rating Scale-IV) between both arms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.